| Literature DB >> 34327465 |
Tamer Yahya1, Mohammad Hashim Jilani2, Safi U Khan3, Reed Mszar4, Syed Zawahir Hassan1, Michael J Blaha5, Ron Blankstein6,7, Salim S Virani8,9, Michelle C Johansen10, Farhaan Vahidy11, Miguel Cainzos-Achirica1,11, Khurram Nasir1,11.
Abstract
Cardiovascular disease remains a major contributor to morbidity and mortality in the US and elsewhere, and stroke is a leading cause of disability worldwide. Despite recent success in diminishing stroke incidence in the general US population, in parallel there is now a concerning propensity for strokes to happen at younger ages. Specifically, the incidence of stroke for US adults 20-44 years of age increased from 17 per 100,000 US adults in 1993 to 28 per 100,000 in 2015. Occurrence of strokes in young adults is particularly problematic as these patients are often affected by physical disability, depression, cognitive impairment and loss of productivity, all of which have vast personal, social and economic implications. These concerning trends among young adults are likely due to increasing trends in the prevalence of modifiable risk factors amongst this population including hypertension, hyperlipidemia, obesity and diabetes, highlighting the importance of early detection and aggressive prevention strategies in the general population at early ages. In parallel and compounding to the issue, troublesome trends are evident regarding increasing rates of substance abuse among young adults. Higher rates of strokes have been noted particularly among young African Americans, indicating the need for tailored prevention and social efforts targeting this and other vulnerable groups, including the primordial prevention of risk factors in the first place, reducing stroke rates in the presence of prevalent risk factors such as hypertension, and improving outcomes through enhanced healthcare access. In this narrative review we aim to emphasize the importance of stroke in young adults as a growing public health issue and increase awareness among clinicians and the public health sector. For this purpose, we summarize the available data on stroke in young adults and discuss the underlying epidemiology, etiology, risk factors, prognosis and opportunities for timely prevention of stroke specifically at young ages. Furthermore, this review highlights the gaps in knowledge and proposes future directions moving forward.Entities:
Keywords: Review; Stroke; Young adults
Year: 2020 PMID: 34327465 PMCID: PMC8315351 DOI: 10.1016/j.ajpc.2020.100085
Source DB: PubMed Journal: Am J Prev Cardiol ISSN: 2666-6677
Fig. 1Incidence of stroke in young adults per 100,000 in the US and Europe. ∗All stroke in patients aged 20–44 Years old. ∗∗ Ischemic stroke in patients aged <55 Years old. Adapted from Ref. [10] Madsen TE, Khoury JC, Leppert M, Alwell K, Moomaw CJ, Sucharew H, Woo D, Ferioli S, Martini S, Adeoye O, Khatri P. Temporal Trends in Stroke Incidence Over Time by Sex and Age in the GCNKSS. Stroke. 2020 Apr; 51 (4):1070–6. [11]; Béjot Y, Daubail B, Jacquin A, Durier J, Osseby GV, Rouaud O, Giroud M. Trends in the incidence of ischaemic stroke in young adults between 1985 and 2011: the Dijon Stroke Registry. Journal of Neurology, Neurosurgery & Psychiatry. 2014 May 1; 85 (5):509–13.
TOAST classification of ischemic stroke.
| TOAST classification | Proportion range |
|---|---|
| Large-artery atherosclerosis | 6–15% |
| Cardioembolism | 10–24% |
| Small-vessel occlusion | 12–26% |
| Stroke of other determined etiology | 9–26% |
| Stroke of undetermined etiology | 24–53% |
Abbreviations: TOAST: Trial of ORG 10172 in Acute Stroke Treatment.
Estimates based on published studies.
Common and uncommon causes of strokes in young adults.
| Common causes | Uncommon causes |
|---|---|
| Middle cerebral artery, internal carotid artery and vertebrobasilar artery | Posterior cerebral artery and anterior cerebral artery |
| Atherothrombotic vasculopathy | |
| Patent foramen ovale, dilated cardiomyopathy, and atrial fibrillation | Infective endocarditis, congenital cardiac malformation, mechanical aortic valve, left ventricular thrombus, hypokinetic left ventricular segment, akinetic left ventricular segment, atrial myxoma and nonbacterial thrombotic endocarditis |
| Dissection of cervical artery and vasculitis | Systemic lupus erythematosus, Hereditary and acquired coagulation disorder, active malignancy and radiation vasculopathy, infective vasculitis, Inflammatory vasculopathy, Hereditary diseases, antiphospholipid antibodies, reversible cerebral vasoconstriction syndrome |
Causes of ICH in young adults.
Primary and secondary causes of hypertension |
arteriovenous malformation, aneurysms, neoplasms, cavernomas |
anticoagulants, antiplatelet drugs, thrombolytics, selective serotonin reuptake inhibitors amphetamine, cocaine, crack, heroin etc. |
severe liver disease, renal disease, infections, pregnancy and the postpartum period, vasculitis, cerebral venous thrombosis, connective tissue disorders, coagulopathies |
Prevalence of risk factors among patients hospitalized with acute ischemic stroke by age and sex.
| HTN | HLD | Diabetes | Tobacco | Obesity | AF | IHD | No RFs∗∗ | 1-2 RFs | 3-5 RFs | |
|---|---|---|---|---|---|---|---|---|---|---|
| 2003–04 | 34.0% | 14.6% | 15.3% | 23.1% | 6.8% | 2.1% | 6.4% | 42.0% | 48.9% | 9.1% |
| 2011–12 | 41.1%∗ | 29.1%∗ | 15.2% | 35.7%∗ | 13.3%∗ | 2.9% | 5.5% | 27.9%∗ | 55.9%∗ | 16.2%∗ |
| 2003–04 | 54.% | 29.0% | 24.3% | 31.3% | 7.7% | 3.2% | 11.1% | 22.8% | 58.6% | 18.6% |
| 2011–12 | 65.9%∗ | 47.8%∗ | 30.3%∗ | 41.7%∗ | 15.2%∗ | 4.3% | 11.2% | 12.1%∗ | 52.9%∗ | 35.0%∗ |
| 2003–04 | 26.1% | 9.6% | 11.8% | 21.1% | 9.1% | 1.7% | 2.1% | 48.6% | 45.8% | 5.6% |
| 2011–12 | 30.7%∗ | 21.7%∗ | 15.5%∗ | 26.5%∗ | 15.7%∗ | 1.8% | 3.9% | 38.5% | 48.0% | 13.5%∗ |
| 2003–04 | 50.1% | 20.8% | 24.2% | 26.9% | 10.9% | 1.2% | 7.3% | 28.1% | 56.5% | 15.4% |
| 2011–12 | 57.3%∗ | 37.8%∗ | 31.4%∗ | 35.8%∗ | 21.0%∗ | 2.3%∗ | 7.2%∗ | 18.6%∗ | 49.9%∗ | 31.6% |
Abbreviations: AF, atrial fibrillation; HLD, lipid disorder; HTN, hypertension; IHD, ischemic heart disease; RF, risk factors; YO, years old. Adapted from Ref. [4] George MG, Tong X, Bowman BA. Prevalence of cardiovascular risk factors and strokes in younger adults. JAMA neurology. 2017 Jun 1; 74(6):695–703.
∗Clinically significant change.
∗∗Risk factors include; (HTN, Diabetes, HLD, Obesity, and Tobacco Use).
Fig. 230-day fatality and cumulative mortality in 30-day survivors of stroke in young adults∗ ∗ Data for ≥ 1-year mortality presented as cumulative incidence of mortality among survivors of first 30 days post-stroke. Adapted from Ref. [54] Rutten-Jacobs LC, Arntz RM, Maaijwee NA, Schoonderwaldt HC, Dorresteijn LD, van Dijk EJ, de Leeuw FE. Long-term mortality after stroke among adults aged 18–50 years. Jama. 2013 Mar 20; 309 (11):1136–44.
Long-term consequences of strokes in young adults.
| Consequence | Description |
|---|---|
| Physical | |
| Functional disability | Main determinant of independence or the need for care-givers, 20–30% reported moderate to severe functional impairment [ |
| Pain Syndromes | Includes headache, central post stroke pain (CPSP), complex regional pain syndrome, and pain associated with spasticity and shoulder subluxation. Data is scarce on the prevalence, especially among the young and for each subtype. CPSP is reported to be present in 6% of young adults with stroke [ Headache is reported in 15%–20% [ |
| Epilepsy | Prevalence is up to 12% of young adults [ |
| Psychosocial | |
| Cognitive impairment | Present in up to 40% of young adults on long term follow up [ |
| Depression | Between 17 and 29% of young stroke patients develop depressive symptoms [ Associated with poor functional outcome and increased risk of suicide [ |
| Anxiety | Between 19 and 23% of young stroke patients develop anxiety [ |
| Fatigue | 41% of young adults with stroke experienced symptoms of fatigue, compared to 18% in controls. Is associated with a poor functional outcome [ |
| Sexual Dysfunction | One study reported that up to one third of young stroke patients develop sexual dysfunction, however, it is believed that depression and the use of ACE inhibitors confounds to it [ |
| Return to work | Between 50% and 70% of young adults with stroke return to work, 25% of whom need adjustments to previous duties. On average, it takes 8 months for patients to return to work [ 20% of the patients who had returned to work at 1 year were not working at 5 years after ischemic stroke Hemorrhagic strokes, large anterior strokes, strokes caused by large artery atherosclerosis, and cardioembolism pose higher risk for not to return to work [ |